<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Devkota S</submitter><funding>NIA NIH HHS</funding><funding>Ministry of Science and Technology of the People&amp;apos;s Republic of China</funding><funding>Key Research and Development Program of Zhejiang Province</funding><funding>National Natural Science Foundation of China</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>National Science Foundation</funding><pagination>113761</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10941010</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(2)</volume><pubmed_abstract>Mutations that cause familial Alzheimer's disease (FAD) are found in amyloid precursor protein (APP) and presenilin, the catalytic component of γ-secretase, that together produce amyloid β-peptide (Aβ). Nevertheless, whether Aβ is the primary disease driver remains controversial. We report here that FAD mutations disrupt initial proteolytic events in the multistep processing of APP substrate C99 by γ-secretase. Cryoelectron microscopy reveals that a substrate mimetic traps γ-secretase during the transition state, and this structure aligns with activated enzyme-substrate complex captured by molecular dynamics simulations. In silico simulations and in cellulo fluorescence microscopy support stabilization of enzyme-substrate complexes by FAD mutations. Neuronal expression of C99 and/or presenilin-1 in Caenorhabditis elegans leads to synaptic loss only with FAD-mutant transgenes. Designed mutations that stabilize the enzyme-substrate complex and block Aβ production likewise led to synaptic loss. Collectively, these findings implicate the stalled process-not the products-of γ-secretase cleavage of substrates in FAD pathogenesis.</pubmed_abstract><journal>Cell reports</journal><pubmed_title>Familial Alzheimer mutations stabilize synaptotoxic γ-secretase-substrate complexes.</pubmed_title><pmcid>PMC10941010</pmcid><funding_grant_id>RF1 AG079569</funding_grant_id><funding_grant_id>P30 AG072973</funding_grant_id><funding_grant_id>R01 GM122894</funding_grant_id><funding_grant_id>R01 AG066986</funding_grant_id><pubmed_authors>Wolfe MS</pubmed_authors><pubmed_authors>Zhou R</pubmed_authors><pubmed_authors>Bhattarai S</pubmed_authors><pubmed_authors>Ackley BD</pubmed_authors><pubmed_authors>Shi Y</pubmed_authors><pubmed_authors>Overmeyer C</pubmed_authors><pubmed_authors>Maesako M</pubmed_authors><pubmed_authors>Do H</pubmed_authors><pubmed_authors>Devkota S</pubmed_authors><pubmed_authors>Saraf A</pubmed_authors><pubmed_authors>Douglas JT</pubmed_authors><pubmed_authors>Miao Y</pubmed_authors><pubmed_authors>Noorani A</pubmed_authors><pubmed_authors>Nagarajan V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Familial Alzheimer mutations stabilize synaptotoxic γ-secretase-substrate complexes.</name><description>Mutations that cause familial Alzheimer's disease (FAD) are found in amyloid precursor protein (APP) and presenilin, the catalytic component of γ-secretase, that together produce amyloid β-peptide (Aβ). Nevertheless, whether Aβ is the primary disease driver remains controversial. We report here that FAD mutations disrupt initial proteolytic events in the multistep processing of APP substrate C99 by γ-secretase. Cryoelectron microscopy reveals that a substrate mimetic traps γ-secretase during the transition state, and this structure aligns with activated enzyme-substrate complex captured by molecular dynamics simulations. In silico simulations and in cellulo fluorescence microscopy support stabilization of enzyme-substrate complexes by FAD mutations. Neuronal expression of C99 and/or presenilin-1 in Caenorhabditis elegans leads to synaptic loss only with FAD-mutant transgenes. Designed mutations that stabilize the enzyme-substrate complex and block Aβ production likewise led to synaptic loss. Collectively, these findings implicate the stalled process-not the products-of γ-secretase cleavage of substrates in FAD pathogenesis.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-01T05:31:53.121Z</modification><creation>2025-02-19T04:36:50.528Z</creation></dates><accession>S-EPMC10941010</accession><cross_references><pubmed>38349793</pubmed><doi>10.1016/j.celrep.2024.113761</doi></cross_references></HashMap>